Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility of pre-procedural [99mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of 90Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [99mTc]TcMAA-based Segmentation.
Lam M, Garin E, Haste P, Denys A, Geller B, Kappadath SC, Turkmen C, Sze DY, Alsuhaibani HS, Herrmann K, Maccauro M, Cantasdemir M, Dreher M, Fowers KD, Gates V, Salem R. Lam M, et al. Among authors: maccauro m. Eur J Nucl Med Mol Imaging. 2024 Sep 27. doi: 10.1007/s00259-024-06920-6. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39331131
Dosimetric optimization of nuclear medicine therapy based on the Council Directive 2013/59/EURATOM and the Italian law N. 101/2020. Position paper and recommendations by the Italian National Associations of Medical Physics (AIFM) and Nuclear Medicine (AIMN).
Chiesa C, Strigari L, Pacilio M, Richetta E, Cannatà V, Stasi M, Marzola MC, Schillaci O, Bagni O, Maccauro M. Chiesa C, et al. Among authors: maccauro m. Phys Med. 2021 Sep;89:317-326. doi: 10.1016/j.ejmp.2021.07.001. Epub 2021 Sep 25. Phys Med. 2021. PMID: 34583307 Free article.
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).
Chiesa C, Botta F, Coliva A, Maccauro M, Devizzi L, Guidetti A, Carlo-Stella C, Seregni E, Gianni MA, Bombardieri E. Chiesa C, et al. Among authors: maccauro m. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1745-57. doi: 10.1007/s00259-009-1141-x. Epub 2009 May 20. Eur J Nucl Med Mol Imaging. 2009. PMID: 19455328 Clinical Trial.
Research reporting standards for radioembolization of hepatic malignancies.
Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB 3rd, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A; Technology Assessment Committee; Interventional Oncology Task Force of the Society of Interventional Radiology. Salem R, et al. Among authors: maccauro m. J Vasc Interv Radiol. 2011 Mar;22(3):265-78. doi: 10.1016/j.jvir.2010.10.029. J Vasc Interv Radiol. 2011. PMID: 21353979 Free PMC article. No abstract available.
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
Chiesa C, Mira M, Maccauro M, Romito R, Spreafico C, Sposito C, Bhoori S, Morosi C, Pellizzari S, Negri A, Civelli E, Lanocita R, Camerini T, Bampo C, Carrara M, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E. Chiesa C, et al. Among authors: maccauro m. Q J Nucl Med Mol Imaging. 2012 Dec;56(6):503-8. Q J Nucl Med Mol Imaging. 2012. PMID: 23358402 Free article.
Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres.
Chiesa C, Lambert B, Maccauro M, Ezziddin S, Ahmadzadehfar H, Dieudonné A, Cremonesi M, Konijnenberg M, Lassmann M, Pettinato C, Strigari L, Vanderlinden B, Crippa F, Flamen P, Garin E. Chiesa C, et al. Among authors: maccauro m. J Nucl Med. 2014 Jul;55(7):1215-6. doi: 10.2967/jnumed.113.129361. Epub 2014 Jun 4. J Nucl Med. 2014. PMID: 24898027 Free article. No abstract available.
Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C, Camerini T, Carrara M, Pellizzari S, Negri A, Aliberti G, Sposito C, Bhoori S, Facciorusso A, Civelli E, Lanocita R, Padovano B, Migliorisi M, De Nile MC, Seregni E, Marchianò A, Crippa F, Mazzaferro V. Chiesa C, et al. Among authors: maccauro m. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1718-1738. doi: 10.1007/s00259-015-3068-8. Epub 2015 Jun 27. Eur J Nucl Med Mol Imaging. 2015. PMID: 26112387
Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship.
Chiesa C, Mira M, Bhoori S, Bormolini G, Maccauro M, Spreafico C, Cascella T, Cavallo A, De Nile MC, Mazzaglia S, Capozza A, Tagliabue G, Brusa A, Marchianò A, Seregni E, Mazzaferro V. Chiesa C, et al. Among authors: maccauro m. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3018-3032. doi: 10.1007/s00259-020-04845-4. Epub 2020 May 25. Eur J Nucl Med Mol Imaging. 2020. PMID: 32451604
84 results